You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Integrase inhibitor

Showing 1 - 25 of 7,501
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

Completed
Has Results
  • HIV
  • Switch to Maraviroc + Raltegravir or Dolutegravir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Oct 5, 2021

HTLV-I Infection Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Raltegravir)

Completed
  • HTLV-I Infection
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

Recruiting
  • HIV/AIDS
  • Antwerp, Belgium
  • +47 more
Jan 9, 2023

HIV Trial in Hangzhou, Beijing, Shanghai (Oral CAB, CAB LA)

Completed
Has Results
  • HIV Infections
  • Oral CAB
  • CAB LA
  • Hangzhou, Zhejiang, China
  • +2 more
May 12, 2021

HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

Recruiting
  • HIV I Infection
  • Adiposity
  • Frequently sampled glucose tolerance testing
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 15, 2022

HIV Trial in United States (Raltegravir (MK-0518), Placebo)

Completed
Has Results
  • HIV Infections
  • Raltegravir (MK-0518)
  • Placebo
  • Birmingham, Alabama
  • +19 more
Nov 2, 2021

HIV Trial in Worldwide (GSK1265744 Tablets, Injectable GSK1265744, Placebo for GSK1265744 Tablets)

Completed
Has Results
  • HIV Infections
  • GSK1265744 Tablets
  • +3 more
  • Los Angeles, California
  • +7 more
Oct 14, 2021

HIV-1-infection, Antiviral Drug Adverse Reaction, Vascular Diseases Trial in Augusta (Dolutegravir 50 MG, Antiretroviral/Anti

Unknown status
  • HIV-1-infection
  • +7 more
  • Dolutegravir 50 MG
  • Antiretroviral/Anti HIV
  • Augusta, Georgia
    Augusta University
Jan 11, 2021

HIV Infection Trial in Worldwide (DTG +DRV/r, SOC)

Completed
  • HIV Infection
  • Buenos Aires, Argentina
  • +30 more
Mar 25, 2021

Human Immunodeficiency Virus Trial in Oakland Park (Symtuza)

Terminated
  • Human Immunodeficiency Virus
  • Oakland Park, Florida
    Midland Research Group, Inc
Dec 3, 2021

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Birmingham, Alabama
  • +180 more
Mar 14, 2022

Effect on HIV Medications on EPC Cells

Completed
  • AIDS
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

Not yet recruiting
  • Metabolic Effects
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

Not yet recruiting
  • Nonalcoholic Fatty Liver Disease
  • +3 more
    • (no location specified)
    Apr 18, 2022

    HIV-1-infection Trial in Paris (Antiretroviral)

    Active, not recruiting
    • HIV-1-infection
    • Paris, France
      Hôpital la Salpêtrière
    Aug 5, 2021

    Hiv, Weight Gain Trial in Toronto (DOR/3TC/TDF)

    Enrolling by invitation
    • Hiv
    • Weight Gain
    • Toronto, Ontario, Canada
      University Health Network
    May 17, 2022

    Bictegravir in the Elderly Living With HIV (BICEP)

    Active, not recruiting
    • HIV-1-infection
    • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
    • Buffalo, New York
      Evergreen Health
    Oct 28, 2022

    HIV-1-infection Trial (Delstrigo, KOCITAF)

    Not yet recruiting
    • HIV-1-infection
    • (no location specified)
    Jun 20, 2023

    HIV-1 Infection Trial in Montpellier (HIV DNA)

    Completed
    • HIV-1 Infection
    • HIV DNA
    • Montpellier, France
      University hospital Montpellier
    Jul 5, 2021

    Liver Cirrhosis Trial in Bunkyo-Ku (OP-724)

    Active, not recruiting
    • Liver Cirrhosis
    • Bunkyo-Ku, Tokyo, Japan
      Tokyo Metropolitan Komagome Hospital
    Jul 7, 2022

    HIV Trial in Johannesburg (Cabotegravir Injection [Apretude], Tenofovir disoproxil fumarate / emtricitabine (or lamivudine))

    Not yet recruiting
    • HIV Infections
    • Cabotegravir Injection [Apretude]
    • Tenofovir disoproxil fumarate / emtricitabine (or lamivudine)
    • Johannesburg, Gauteng, South Africa
      Ezintsha, a division of Wits Health Consortium
    Nov 13, 2023

    Different Integrase Inhibitor Based Regimen on Immune Activation

    Completed
    • HIV Infections
      • Brescia, BS, Italy
        AO Spedali Civili di Brescia
      Jan 14, 2019

      HIV-1 Infection Trial in France (Samplings)

      Recruiting
      • HIV-1 Infection
      • Samplings
      • Clamart, France
      • +6 more
      Jan 4, 2022

      HIV Trial in Sevilla (Continue with triple therapy, Switch to DTG + 3TC, Switch to DRV/cobicistat + 3TC)

      Completed
      • HIV Infections
      • Continue with triple therapy
      • +2 more
      • Sevilla, Spain
        Virgen del Rocio University Hospital
      Aug 27, 2021